Low-Burden TP53 mutations occur in chronic phase of myeloproliferative neoplasms regardless of hydroxyurea administration, disease type and JAK2 status

Investor logo

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors

KUBEŠOVÁ Blanka PAVLOVÁ Šárka MALČÍKOVÁ Jitka KABÁTHOVÁ Jitka RADOVÁ Lenka TOM Nikola TICHÝ Boris PLEVOVÁ Karla KANTOROVÁ Barbara FIEDOROVÁ Kristýna KISSOVÁ Jarmila GISSLINGER B. GISSLINGER H. MAYER Jiří KRALOVICS Robert POSPÍŠILOVÁ Šárka DOUBEK Michael

Year of publication 2016
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info